Delivery Order SPE2DB22D1017-SPE2DB24FG4AF
Award Date
8/27/24
Potential Completion Date
8/28/24
Potential Value
$17K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The contract, valued at $15,685.00, is for the delivery of GARDASIL 9 SYRINGE 0.5ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of September 18, 2024. This contract is not designated as a set-aside and is likely part of a larger Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office Division. The $3,233.58 firm-fixed-price delivery order is for the supply of 4,565,699 units of the GARDASIL 9 vaccine syringe (0.5mL) with no set-aside designation. The contract has an ultimate completion date of September 6, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and...
This federal contract award, valued at $10,458.74, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of GARDASIL 9 SYRINGE 0.5ML, a pharmaceutical product, with a completion date of July 19, 2024. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the...
This federal contract award, valued at $14,757.05, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order for the supply of GARDASIL 9 SYRINGE 0.5ML, a critical vaccine product. The contract has a firm fixed price pricing type and an ultimate completion date of June 27, 2024. AmerisourceBergen, through its Corporate Office division, will deliver these medical supplies to support the DLA Troop Support...
This federal contract award was issued by the Medical Supply Chain, a division of the Defense agency, to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of GARDASIL 9 SYRINGE 0.5ML. The $3,233.58 firm fixed price delivery order has an ultimate completion date of April 18, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the Department of Defense (DoD) and Veterans...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $3,779.26 firm fixed-price delivery order is for the supply of GARDASIL 9 SYRINGE 0.5ML, a pharmaceutical product, to support various military treatment facilities and healthcare programs. The contract has an ultimate completion date of August 15, 2024 and is not designated as a set-aside. AmerisourceBergen, a major pharmaceutical distributor, has...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $9,411.00, is for the delivery of GARDASIL 9 SYRINGE 0.5ML, a vaccine product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of October 30, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp. The contract, valued at $10,158.90, is for the delivery of GARDASIL 9 SYRINGE 0.5ML, a pharmaceutical product. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of August 8, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S....
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the supply of GARDASIL 9 syringes (0.5 mL) to the Defense Logistics Agency (DLA) Troop Support Medical. The $10,321.87 firm fixed-price delivery order has an ultimate completion date of October 9, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a range of medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of GARDASIL 9 SYRINGE 0.5ML. The firm-fixed price contract, valued at $10,581.57, has an ultimate completion date of December 4, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical...